Zhang Q - Search Results

1

Correction: HERC2 promotes inflammation-driven cancer stemness and immune evasion in hepatocellular carcinoma by activating STAT3 pathway.

Liu Y, Xu Q, Deng F, Zheng Z, Luo J, Wang P, Zhou J, Lu X, Zhang L, Chen Z, Zhang Q, Chen Q, Zuo D. Liu Y, et al. Among authors: zhang l, zhang q. J Exp Clin Cancer Res. 2024 Nov 13;43(1):300. doi: 10.1186/s13046-024-03223-4. J Exp Clin Cancer Res. 2024. PMID: 39538344 Free PMC article. No abstract available.

2

HERC2 promotes inflammation-driven cancer stemness and immune evasion in hepatocellular carcinoma by activating STAT3 pathway.

Liu Y, Xu Q, Deng F, Zheng Z, Luo J, Wang P, Zhou J, Lu X, Zhang L, Chen Z, Zhang Q, Chen Q, Zuo D. Liu Y, et al. Among authors: zhang l, zhang q. J Exp Clin Cancer Res. 2023 Feb 1;42(1):38. doi: 10.1186/s13046-023-02609-0. J Exp Clin Cancer Res. 2023. PMID: 36721234 Free PMC article.

3

Integrative epigenetic analysis reveals AP-1 promotes activation of tumor-infiltrating regulatory T cells in HCC.

Zhuo B, Zhang Q, Xie T, Wang Y, Chen Z, Zuo D, Guo B. Zhuo B, et al. Among authors: zhang q. Cell Mol Life Sci. 2023 Mar 20;80(4):103. doi: 10.1007/s00018-023-04746-3. Cell Mol Life Sci. 2023. PMID: 36941472 Free PMC article.

4

Expression of Allograft Inflammatory Factor-1 (AIF-1) in Hepatocellular Carcinoma.

Zhang Q, Sun S, Zhu C, Xie F, Cai Q, Sun H, Chen G, Liang X, Xie H, Shi J, Liao Y, Zhou J. Zhang Q, et al. Med Sci Monit. 2018 Sep 6;24:6218-6228. doi: 10.12659/MSM.908510. Med Sci Monit. 2018. PMID: 30188879 Free PMC article.

5

Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma.

Zhang Q, Xiao Z, Sun S, Wang K, Qian J, Cui Z, Tao T, Zhou J. Zhang Q, et al. Cancer Manag Res. 2021 Mar 11;13:2307-2317. doi: 10.2147/CMAR.S291811. eCollection 2021. Cancer Manag Res. 2021. PMID: 33732023 Free PMC article.

6

miR-942 promotes proliferation and metastasis of hepatocellular carcinoma cells by inhibiting RRM2B.

Zhang Q, Zhu B, Qian J, Wang K, Zhou J. Zhang Q, et al. Onco Targets Ther. 2019 Oct 11;12:8367-8378. doi: 10.2147/OTT.S207549. eCollection 2019. Onco Targets Ther. 2019. PMID: 31632084 Free PMC article.

7

ACOX2 is a prognostic marker and impedes the progression of hepatocellular carcinoma via PPARα pathway.

Zhang Q, Zhang Y, Sun S, Wang K, Qian J, Cui Z, Tao T, Zhou J. Zhang Q, et al. Among authors: zhang y. Cell Death Dis. 2021 Jan 4;12(1):15. doi: 10.1038/s41419-020-03291-2. Cell Death Dis. 2021. PMID: 33414412 Free PMC article.

8

Characterization of somatic mutations and pathway alterations during hepatocellular carcinoma vascular invasion using next-generation sequencing.

Li Q, Zhang Q, Chen J, Zang M, Hu X, Li R, Hou J, Zhou J. Li Q, et al. Among authors: zhang q. J Gastrointest Oncol. 2022 Aug;13(4):1864-1874. doi: 10.21037/jgo-22-556. J Gastrointest Oncol. 2022. PMID: 36092348 Free PMC article.

9

Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.

Zhang Q, Sun S, Zhu C, Zheng Y, Cai Q, Liang X, Xie H, Zhou J. Zhang Q, et al. Mol Med Rep. 2019 Apr;19(4):2479-2488. doi: 10.3892/mmr.2019.9929. Epub 2019 Feb 4. Mol Med Rep. 2019. PMID: 30720105 Free PMC article.

10

Safety and efficacy of postoperative adjuvant therapy with atezolizumab and bevacizumab after radical resection of hepatocellular carcinoma.

Li ZX, Zhang QF, Huang JM, Huang SJ, Liang HB, Chen H, Lai ZH, Li QY, Qian JP, Wang K, Zhou J. Li ZX, et al. Clin Res Hepatol Gastroenterol. 2023 Aug;47(7):102165. doi: 10.1016/j.clinre.2023.102165. Epub 2023 Jun 15. Clin Res Hepatol Gastroenterol. 2023. PMID: 37330005

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70,011 results

Search Page

Filters